Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort.
Br J Cancer
; 121(12): 1001-1008, 2019 12.
Article
in En
| MEDLINE
| ID: mdl-31719685
Full text:
1
Database:
MEDLINE
Main subject:
Bone Neoplasms
/
Taxoids
/
Prostatic Neoplasms, Castration-Resistant
/
Lymphatic Metastasis
Type of study:
Risk_factors_studies
Limits:
Aged
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Br J Cancer
Year:
2019
Type:
Article
Affiliation country:
France